Medico Intercontinental

Medico Intercontinental Interest Coverage

The Interest Coverage Ratio of Medico Intercontinental (539938.BO) as of Oct 28, 2026 is 8.00. In the previous year, Interest Coverage Ratio was 12.03 — a change of -33.46% (lower).

Interest Coverage

8.00

YoY

-33.46%

Last updated:

Interest Coverage Ratio of Medico Intercontinental is 2025 8.00 . Interest Coverage Ratio of Medico Intercontinental was 2024 12.03 . It decreases by -33.46% lower compared to the previous year.

The Medico Intercontinental Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2021
3.76 INR
Jan 1, 2022
5.90 INR
Jan 1, 2023
9.10 INR
Jan 1, 2024
12.03 INR
Jan 1, 2025
8.00 INR
The Medico Intercontinental Interest Coverage history
YEARInterest CoverageYoY
8.00-33.46%
12.03+32.16%
9.10+54.26%
5.90+56.94%
3.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medico Intercontinental Stock analysis

What does Medico Intercontinental do? Medico Intercontinental Ltd. generates revenue through financing, trading, and investment in shares and securities. The company provides a platform for research-based biopharmaceutical companies, focusing on product categories such as gastro, uro, nutrition, cosmetology, health devices, and hospital services. Its product portfolio includes ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, and other branded pharmaceuticals like CYCLOFACT 400, UDIFACT 150, and ZIFT SL - 250. Subsidiaries such as Evagrace Pharma Private Limited and Ritz Formulations Private Limited support its operations in the biopharmaceutical sector. The company serves biopharmaceutical firms seeking research-based solutions, with products distributed across gastroenterology, urology, nutrition, and cosmetology segments. Key brands like ALFACARE - D3, ARSUFACT Combokit, and BALOFACT target specific medical needs, while health devices and hospital-related products cater to broader healthcare markets. Subsidiaries like Sungrace Pharma Private Limited and Azillian Healthcare Private Limited contribute to the company's product development and market reach. Medico Intercontinental Ltd. monetizes its platform by facilitating trading and investment activities in securities, alongside its biopharmaceutical product sales. The company's subsidiaries manage production and distribution of branded pharmaceuticals, ensuring market presence in key healthcare segments. Products such as RELIEVE CZ, VOLIREX SPRAY, and ZYMIX SY are sold to healthcare providers and consumers in the biopharmaceutical industry. Medico Intercontinental is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medico Intercontinental stock

Interest Coverage Ratio of Medico Intercontinental is 8.00 in 2025.

Interest Coverage Ratio of Medico Intercontinental changed from 12.03 to 8.00, representing a -33.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Medico Intercontinental since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Medico Intercontinental with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Medico Intercontinental

All Key Metrics — Medico Intercontinental